• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by AdvanSix Inc.

    5/16/25 5:16:37 PM ET
    $ASIX
    Major Chemicals
    Industrials
    Get the next $ASIX alert in real time by email
    DEFA14A 1 defa14amay162025.htm DEFA14A Document


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    SCHEDULE 14A
     
    Proxy Statement Pursuant to Section 14(a) of the
    Securities Exchange Act of 1934 (Amendment No.      )  
    Filed by the Registrant x
    Filed by a party other than the Registrant o
    Check the appropriate box:
    o
    Preliminary Proxy Statement
    oConfidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
    oDefinitive Proxy Statement
    x
    Definitive Additional Materials
    oSoliciting Material under §240.14a-12
    AdvanSix Inc.
    (Name of Registrant as Specified In Its Charter)
     
    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)
     
    Payment of Filing Fee (Check all boxes that apply):
    xNo fee required.
    o
    Fee paid previously with preliminary materials.
    o
    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.







    imagea.jpg

    300 Kimball Drive, Suite 101
    Parsippany, New Jersey 07054

    PROXY STATEMENT SUPPLEMENT

    This supplement (this “Supplement”) supplements the definitive proxy statement filed by AdvanSix Inc. (the “Company”) with the U.S. Securities and Exchange Commission (“SEC”) on April 29, 2025 (the “2025 Proxy Statement”) and made available to the Company’s stockholders in connection with the solicitation of proxies by the Company’s Board of Directors (the “Board”) for use at the 2025 Annual Meeting of Stockholders, to be held virtually on Wednesday, June 18, 2025 at 9:00 a.m., Eastern Time (the “Annual Meeting”). This Supplement is being filed with the SEC and made available to stockholders on or about May 16, 2025.

    This Supplement is being filed to update the disclosure in the 2025 Proxy Statement under the heading “Voting Procedures — Quorum; Vote Required; Abstentions and Broker Non-Votes” to revise the description of the impact of abstentions on each of Proposal Nos. 2, 3, and 4 in the 2025 Proxy Statement. That section is hereby revised in its entirety to read as follows:

    QUORUM; VOTE REQUIRED; ABSTENTIONS AND BROKER NON-VOTES

    The required quorum for the transaction of business at the meeting is a majority of the total outstanding shares of Common Stock entitled to vote at the meeting, either present at the Annual Meeting or represented by proxy. Abstentions and broker non-votes are counted for purposes of establishing a quorum.

    Regarding Proposal No. 1, AdvanSix’s By-laws provide that in any uncontested election of directors (an election in which the number of nominees does not exceed the number of directors to be elected), any nominee who receives a greater number of votes cast “FOR” his or her election than votes cast “AGAINST” his or her election will be elected to the Board of Directors. Shares not represented at or by proxy at the Annual Meeting of Stockholders, abstentions and broker non-votes will have no effect on the election of directors. The By-laws also provide that any incumbent director nominee who does not receive a majority of votes cast in an uncontested election is expected to promptly tender his or her resignation to the Chair of the Board following the certification of the stockholder vote. This resignation will be promptly considered through a process managed by the Nominating and Governance Committee, excluding any director nominee who did not receive a majority of votes cast to elect him or her to the Board.

    The affirmative vote of a majority of the votes cast by stockholders who are present or represented and entitled to vote on each of Proposal Nos. 2, 3, and 4 is required for approval of these proposals. Shares not represented at or by proxy at the Annual Meeting, abstentions and broker non-votes will have no effect on these proposals.

    The affirmative vote of a majority of our outstanding stock is required for approval of Proposal No. 5. Shares not represented at or by proxy at the Annual Meeting, abstentions and broker non-votes will have the effect of an “AGAINST” vote on this proposal.

    Other than as described in this Supplement, the information in the 2025 Proxy Statement remains unchanged, and this Supplement does not otherwise modify or update the 2025 Proxy Statement or the proposals to be acted upon at the Annual Meeting as described therein. From and after the date of this Supplement, any references to the “Proxy Statement” are to the 2025 Proxy Statement as supplemented by this Supplement. This Supplement should be read in conjunction with the 2025 Proxy Statement and the other proxy materials previously made available to stockholders in connection with the Annual Meeting.

    If you have already voted or directed the vote of your shares by Internet, mobile device, telephone or mail, you do not need to vote again or otherwise take any action unless you would like to change or revoke your prior vote on any proposal.

    Get the next $ASIX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASIX

    DatePrice TargetRatingAnalyst
    1/15/2026$19.00Hold
    Truist
    5/19/2025$32.00Neutral → Overweight
    Piper Sandler
    4/7/2025$26.00Overweight → Neutral
    Piper Sandler
    11/12/2021$58.00Overweight
    Piper Sandler
    More analyst ratings

    $ASIX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Newman Donald P bought $149,089 worth of shares (5,030 units at $29.64) (SEC Form 4)

    4 - AdvanSix Inc. (0001673985) (Issuer)

    11/19/24 4:20:20 PM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Truist initiated coverage on AdvanSix with a new price target

    Truist initiated coverage of AdvanSix with a rating of Hold and set a new price target of $19.00

    1/15/26 8:33:55 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded AdvanSix from Neutral to Overweight and set a new price target of $32.00

    5/19/25 8:45:52 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded AdvanSix from Overweight to Neutral and set a new price target of $26.00

    4/7/25 8:48:39 AM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by AdvanSix Inc.

    SCHEDULE 13G/A - AdvanSix Inc. (0001673985) (Subject)

    1/30/26 1:26:08 PM ET
    $ASIX
    Major Chemicals
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by AdvanSix Inc.

    SCHEDULE 13G/A - AdvanSix Inc. (0001673985) (Subject)

    1/21/26 1:21:11 PM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - AdvanSix Inc. (0001673985) (Filer)

    12/22/25 4:15:38 PM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Bird Jeffrey J. claimed no ownership of stock in the company (SEC Form 3)

    3 - AdvanSix Inc. (0001673985) (Issuer)

    1/5/26 4:44:45 PM ET
    $ASIX
    Major Chemicals
    Industrials

    Director Newman Donald P was granted 1,721 shares, increasing direct ownership by 13% to 15,306 units (SEC Form 4)

    4 - AdvanSix Inc. (0001673985) (Issuer)

    12/17/25 4:22:07 PM ET
    $ASIX
    Major Chemicals
    Industrials

    Director Williams Patrick was granted 821 shares, increasing direct ownership by 2% to 35,923 units (SEC Form 4)

    4 - AdvanSix Inc. (0001673985) (Issuer)

    12/17/25 4:19:46 PM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AdvanSix to Release Fourth Quarter Financial Results and Hold Investor Conference Call on February 20

    AdvanSix (NYSE:ASIX), an integrated chemistry company serving diverse end markets, will issue its fourth quarter and full year 2025 financial results before the opening of the New York Stock Exchange on Friday, February 20. The company will also hold a conference call with investors at 9:30 a.m. ET that day. Conference Call Details To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start and tell the operator that you are dialing in for AdvanSix's fourth quarter 2025 earnings call. A replay of the conference call will be available from 12 noon ET on February 20 until 12 noon ET on Febru

    1/20/26 6:50:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix Appoints Jeffrey J. Bird to Board of Directors

    AdvanSix (NYSE:ASIX), an integrated chemistry company serving diverse end markets, announced today the appointment of Jeffrey J. Bird as a new independent member of its Board of Directors, effective January 1, 2026. Mr. Bird is currently Interim President and Chief Operating Officer of Envent Corporation, a private company that provides environmental and industrial solutions for the petrochemical industry that minimize environmental impact while maximizing operational efficiency, where he has also served as a member of the Board of Advisors since January 2025. He also serves as a director of Heath Consultants, a private company specializing in methane detection. With Mr. Bird's appointm

    12/22/25 4:15:00 PM ET
    $ASIX
    Major Chemicals
    Industrials

    CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 22, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space.  Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Dec 22, 2025  S&P 500 Addition CRH CRH Mat

    12/5/25 5:49:00 PM ET
    $ASIX
    $BAH
    $BWA
    Major Chemicals
    Industrials
    Professional Services
    Consumer Discretionary

    $ASIX
    Leadership Updates

    Live Leadership Updates

    View All

    AdvanSix Appoints Jeffrey J. Bird to Board of Directors

    AdvanSix (NYSE:ASIX), an integrated chemistry company serving diverse end markets, announced today the appointment of Jeffrey J. Bird as a new independent member of its Board of Directors, effective January 1, 2026. Mr. Bird is currently Interim President and Chief Operating Officer of Envent Corporation, a private company that provides environmental and industrial solutions for the petrochemical industry that minimize environmental impact while maximizing operational efficiency, where he has also served as a member of the Board of Advisors since January 2025. He also serves as a director of Heath Consultants, a private company specializing in methane detection. With Mr. Bird's appointm

    12/22/25 4:15:00 PM ET
    $ASIX
    Major Chemicals
    Industrials

    CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 22, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space.  Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Dec 22, 2025  S&P 500 Addition CRH CRH Mat

    12/5/25 5:49:00 PM ET
    $ASIX
    $BAH
    $BWA
    Major Chemicals
    Industrials
    Professional Services
    Consumer Discretionary

    AdvanSix Appoints Dana O'Brien and Daryl Roberts to Board of Directors

    AdvanSix (NYSE:ASIX), a diversified chemistry company, announced today the appointment of Dana O'Brien and Daryl Roberts as new independent members of its Board of Directors. Ms. O'Brien recently retired as Senior Vice President and Chief Legal Officer of Olin Corporation, a leading vertically integrated global manufacturer and distributor of chemical products. Ms. O'Brien will serve on the Nominating and Governance Committee and the Compensation and Leadership Development Committee of the Board. Mr. Roberts is currently Senior Vice President and Chief Operations and Engineering Officer of DuPont de Nemours Inc., a global innovation leader with technology-based materials and solutions t

    9/2/25 4:15:00 PM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by AdvanSix Inc. (Amendment)

    SC 13G/A - AdvanSix Inc. (0001673985) (Subject)

    2/13/24 4:55:58 PM ET
    $ASIX
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by AdvanSix Inc. (Amendment)

    SC 13G/A - AdvanSix Inc. (0001673985) (Subject)

    2/9/24 9:58:57 AM ET
    $ASIX
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by AdvanSix Inc.

    SC 13G - AdvanSix Inc. (0001673985) (Subject)

    2/7/24 8:39:58 AM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Financials

    Live finance-specific insights

    View All

    AdvanSix to Release Fourth Quarter Financial Results and Hold Investor Conference Call on February 20

    AdvanSix (NYSE:ASIX), an integrated chemistry company serving diverse end markets, will issue its fourth quarter and full year 2025 financial results before the opening of the New York Stock Exchange on Friday, February 20. The company will also hold a conference call with investors at 9:30 a.m. ET that day. Conference Call Details To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start and tell the operator that you are dialing in for AdvanSix's fourth quarter 2025 earnings call. A replay of the conference call will be available from 12 noon ET on February 20 until 12 noon ET on Febru

    1/20/26 6:50:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix Announces Third Quarter 2025 Financial Results

    3Q25 Sales of $374 million, down 6% versus prior year 3Q25 Earnings Per Share of ($0.10); Adjusted Earnings Per Share of $0.08 3Q25 Cash Flow from Operations of $27 million AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the third quarter ending September 30, 2025. Overall, the Company continued to navigate challenging industry dynamics with a focus on optimizing operational and commercial performance. Third Quarter 2025 Summary "In the third quarter, our team executed with agility and discipline as we seasonally entered a new fertilizer year in Plant Nutrients with a strong fall fill program, amid higher raw material input costs, while

    11/7/25 6:30:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix to Release Third Quarter Financial Results and Hold Investor Conference Call on November 7

    AdvanSix (NYSE:ASIX), a diversified chemistry company, will issue its third quarter 2025 financial results before the opening of the New York Stock Exchange on Friday, November 7. The company will also hold a conference call with investors at 9:30 a.m. ET that day. Conference Call Details To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start and tell the operator that you are dialing in for AdvanSix's third quarter 2025 earnings call. A replay of the conference call will be available from 12 noon ET on November 7 until 12 noon ET on November 14. You can listen to the replay by dialin

    10/14/25 6:50:00 AM ET
    $ASIX
    Major Chemicals
    Industrials